Alkem Laboratories has denied allegations by the CDSCO that certain batches of its products, Pan-D and Clavam 625, failed to meet quality standards. The company asserted that the samples in question were fake after comparing them with actual batches. Alkem's stock price saw a slight decline before closing marginally lower.